MedTrace Logo

Feasibility Study of Take-Home LAAM Medication - 3

NCT00000300 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2017-11-01

No results posted yet for this study

Summary

The purpose of this study is to test therapeutic benefits of take-home LAAM. (1) Do subjects with take-home LAAM availability show increased clinical responsibility over subjects without; (2) Do subjects with take-home LAAM attempt diversion when random recall and other diversion safeguards are used; (3) Does treatment response correlate with background or drug use variables at intake, discharge, or during treatment?

Conditions

  • Opioid-Related Disorders

Interventions

DRUG

LAAM

Sponsors & Collaborators

Principal Investigators

  • Walter Ling, M.D. · Friends Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000300 on ClinicalTrials.gov